Package 0363-1235-27

Brand: migraine relief

Generic: acetaminophen, aspirin, caffeine
NDC Package

Package Facts

Identity

Package NDC 0363-1235-27
Digits Only 0363123527
Product NDC 0363-1235
Description

1 BOTTLE in 1 CARTON (0363-1235-27) / 80 TABLET, FILM COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2025-01-09
Brand migraine relief
Generic acetaminophen, aspirin, caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0adbc221-6d29-4d14-82b9-bcf0b97a560c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["36503181-0fda-4127-b3f0-bdb1b56bb0ed"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Walgreen Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0363-1235-27)  / 80 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0363-1235-27", "marketing_start_date": "20250109"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0363-1235-60)  / 20 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0363-1235-60", "marketing_start_date": "20220616"}], "brand_name": "migraine relief", "product_id": "0363-1235_0adbc221-6d29-4d14-82b9-bcf0b97a560c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0363-1235", "generic_name": "acetaminophen, aspirin, caffeine", "labeler_name": "Walgreen Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "migraine relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA075794", "marketing_category": "ANDA", "marketing_start_date": "20220616", "listing_expiration_date": "20261231"}